In August 2006, REMICADE was approed for inhibiting progression of structural damage and improing physical function in patients with psoriatic arthritis.

• 2006年8月证实，英夫利昔单抗治疗银屑病关节炎，可抑制结构破坏进展，改善躯体功能。